Vaccine ecosystem health check

Identifying the components and experiencing the complexities

Thursday, 3 October 2019 | 09:00-11:30 | Kursaal C

Organised by MSD and Sanofi

The recent EU initiatives on vaccination reveal the unique complexity of the vaccine ecosystem. Decisions on, but not limited to, prioritisation of new pathogens for research and development (R&D), regulatory requirements, manufacturing and supply capacity, industrial and technology policies, procurement, pricing policies, forecasting and stockpiling practices, and financing of vaccination programmes, all impact access to vaccines globally and in a given country. Ultimately, the result should lead to a predictable and sustainable supply of innovative, qualitative and affordable vaccines to meet public health needs.

This session will aim to help the audience understand and recognise the many different components of a vaccine ecosystem, and how they are all interconnected. It will feature a panel debate followed by an interactive simulation exercise, providing the forum for participants not only to listen to experts, but actively take part and understand their respective roles as well.

Photo Gallery

Session Report


Session Recording

Speakers & panellists


  • Panos Kanavos, Associate Professor of International Health Policy, London School of Economics and Political Science


  • Rute Horta, Executive Director, National Association of Pharmacies, Portugal
  • Alexander Kort, SVP Corporate Development, Themis Bioscience GmbH
  • Antonio Gaudioso, Secretary General, Cittadinanzattiva (Active Citizenship)
  • Adrian Pana, Health Policy Analyst, Founder & CEO, Center for Health Outcomes and Evaluation
  • Wolfgang Philipp, Deputy Head of Unit, DG SANTE (C3), European Commission


EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office